UG - United-Guardian, Inc. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

UNITED-GUARDIAN, INC.

NASDAQ

$7.15

▼ DOWN 0.69% (-0.05)

KEY STATISTICS

Market Cap$32.85 M

52w High$8.78

52w Low$5.58

Dividend Yield3.90%

FrequencySemi-Annual

P/E13.75

Volume9.32K

Shares Out.4.59M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Donna Vigilante

COMPENSATION 2026

Salary$0

Stock Awards$0

Incentive Plan Pay$0

All Other Comp.$0

Total$0

ABOUT

SECTOR

Consumer Defensive

WENT PUBLIC

March 17, 1980

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

SPLIT RECORD

DATE	TYPE	RATIO
1985-09-12	Forward	6:5
1985-02-26	Forward	11:10
1984-04-17	Forward	21:20

PRICE

$7.15 ▼ DOWN 0.69% (−$0.05)

OVERLAYS

About United-Guardian, Inc.

https://www.u-g.com ↗

United-Guardian, Inc. develops and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and industrial products globally, with a focus on innovative formulations and R&D since 1942.

INDUSTRY

Household & Personal Products

A PRODUCT UNITED-GUARDIAN, INC. IS KNOWN FOR

Renacidin

Renacidin, developed by United-Guardian, Inc., is a prescription drug that prevents and dissolves urinary calcifications, serving a vital role in the company's pharmaceutical portfolio and generating significant revenue through sales to drug whole...